Prof Monty Mythen

Photo

Personal Profile

Name: Monty Mythen Email: m.mythen@ucl.ac.uk
Title: Prof Tel: 0044 020 7679 6639
Department: ICH Infect, Imm, Infla. & Physio Med Fax: 0044 020 7679 0876
Position: Smiths Medical Professor of Anaesthesia and Critical Care Address: 1st Floor Maple House, 149 Tottenham Court Road, London, W1T 7DN
Research Domain: Cardiometabolic Science, Personalised Medicine, Populations & Lifelong Health Web Page: Personal Web Page

Profile

Research Description

Pathogenesis of post-operative organ dysfunction and therapeutic interventions that improve outcome. Haemodynamic measurements and fluid therapy.

Research Activities

Critical Care Medicine

Education Description

Regular lectures at National and International Conferences.

UCL Collaborators

Dr Mike Grocott; Dr Geoffrey Bellingan; Prof Mark Peters; Prof Hugh Montgomery; Prof John Martin; Prof Mervyn Singer; Prof Steve Humphries; Prof Aroon Hingorani

External Collaborators

Publications

    2014

    • Wade DM, Hankins M, Smyth DA, Rhone EE, Mythen MG, Howell D, Weinman JA (2014). Detecting acute distress and risk of future psychological morbidity in critically ill patients: Validation of the Intensive care psychological assessment tool.. Crit Care, 18(5), 519 - . doi:10.1186/s13054-014-0519-8
    • Rosner MH, Ostermann M, Murugan R, Prowle JR, Ronco C, Kellum JA, Mythen MG, Shaw AD, for the ADQI XII Investigators Group (2014). Indications and management of mechanical fluid removal in critical illness.. Br J Anaesth, , - . doi:10.1093/bja/aeu297
    • Miller TE, Mythen M (2014). Successful recovery after major surgery: moving beyond length of stay.. Perioper Med (Lond), 3, 4 - . doi:10.1186/2047-0525-3-4
    • Moonesinghe SR, Harris S, Mythen MG, Rowan KM, Haddad FS, Emberton M, Grocott MP (2014). Survival after postoperative morbidity: a longitudinal observational cohort study†. Br J Anaesth, , - . doi:10.1093/bja/aeu224
    • Wade DM, Brewin CR, Howell DC, White E, Mythen MG, Weinman JA (2014). Intrusive memories of hallucinations and delusions in traumatized intensive care patients: An interview study.. Br J Health Psychol, , - . doi:10.1111/bjhp.12109
    • Siervo M, Riley HL, Fernandez BO, Leckstrom CA, Martin DS, Mitchell K, Levett DZ, Montgomery HE, Mythen MG, Grocott MP, Feelisch M, Caudwell Xtreme Everest Research Group (2014). Effects of prolonged exposure to hypobaric hypoxia on oxidative stress, inflammation and gluco-insular regulation: the not-so-sweet price for good regulation.. PLoS One, 9(4), e94915 - . doi:10.1371/journal.pone.0094915
    • Harvey SE, Parrott F, Harrison DA, Bear DE, Segaran E, Beale R, Bellingan G, Leonard R, Mythen MG, Rowan KM, the CALORIES Trial Investigators (2014). Trial of the Route of Early Nutritional Support in Critically Ill Adults.. N Engl J Med, , - . doi:10.1056/NEJMoa1409860
    • Chawla LS, Ince C, Chappell D, Gan TJ, Kellum JA, Mythen M, Shaw A, for the ADQI XII Fluids Workgroup (2014). Vascular content, tone, integrity, and haemodynamics for guiding fluid therapy: a conceptual approach.. Br J Anaesth, , - . doi:10.1093/bja/aeu298
    • Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, Kellum JA, Mythen MG, Shaw AD, for the ADQI XII Investigators Group (2014). Four phases of intravenous fluid therapy: a conceptual model.. Br J Anaesth, , - . doi:10.1093/bja/aeu300
    • Goldstein S, Bagshaw S, Cecconi M, Okusa M, Wang H, Kellum J, Mythen M, Shaw A, for the ADQI XII Investigators Group (2014). Pharmacological management of fluid overload.. Br J Anaesth, , - . doi:10.1093/bja/aeu299
    • Cannesson M, Ani F, Mythen MM, Kain Z (2014). Anaesthesiology and perioperative medicine around the world: different names, same goals.. Br J Anaesth, , - . doi:10.1093/bja/aeu265
    • Edwards MR, Mythen MG (2014). Fluid therapy in critical illness.. Extrem Physiol Med, 3, 16 - . doi:10.1186/2046-7648-3-16

    2013

    • Moonesinghe SR, Harris S, Mythen MG, Rowan KM, Emberton M, Haddad FS, Grocott MPW (2013). Prolonged postoperative morbidity is an independent risk factor for reduced long-term survival.
    • Butterworth JF, Mythen MG (2013). Should "normal" saline be our usual choice in normal surgical patients?. Anesth Analg, 117(2), 290 - 291. doi:10.1213/ANE.0b013e31828a73f1
    • Wade D, Hardy R, Howell D, Mythen M (2013). Identifying clinical and acute psychological risk factors for PTSD after critical care: a systematic review.. Minerva Anestesiol, 79(8), 944 - 963.
    • Moonesinghe SR, Mythen MG, Das P, Rowan KM, Grocott MPW (2013). Risk Stratification Tools for Predicting Morbidity and Mortality in Adult Patients Undergoing Major Surgery Qualitative Systematic Review. ANESTHESIOLOGY, 119(4), 959 - 981. doi:10.1097/ALN.0b013e3182a4e94d
    • Vincent JL, Kellum JA, Shaw A, Mythen MG (2013). Should hydroxyethyl starch solutions be totally banned?. Crit Care, 17(5), 193 - . doi:10.1186/cc13027
    • Myburgh JA, Mythen MG (2013). Resuscitation fluids.. N Engl J Med, 369(13), 1243 - 1251. doi:10.1056/NEJMra1208627
    • Martin DS, Gilbert-Kawai ET, Meale PM, Fernandez BO, Cobb A, Khosravi M, Mitchell K, Grocott MP, Levett DZ, Mythen MG, Feelisch M, for the Xtreme Alps Research Group (2013). Design and conduct of 'Xtreme Alps': A double-blind, randomised controlled study of the effects of dietary nitrate supplementation on acclimatisation to high altitude.. Contemp Clin Trials, , - . doi:10.1016/j.cct.2013.09.002
    • Van Der Linden P, James M, Mythen M, Weiskopf RB (2013). Safety of modern starches used during surgery.. Anesth Analg, 116(1), 35 - 48. doi:10.1213/ANE.0b013e31827175da
    • Myburgh JA, Mythen MG (2013). Resuscitation Fluids REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 369(25), 2462 - 2463.
    • Myburgh JA, Mythen MG (2013). Resuscitation fluids.. N Engl J Med, 369(25), 2462 - 2463. doi:10.1056/NEJMc1313345
    • Martin DS, Gilbert-Kawai E, Levett DZH, Mitchell K, Kumar Bc R, Mythen MG, Grocott MP (2013). Xtreme Everest 2: unlocking the secrets of the Sherpa phenotype?. Extrem Physiol Med, 2(1), 30 - . doi:10.1186/2046-7648-2-30
    • Gillies MA, Habicher M, Jhanji S, Sander M, Mythen M, Hamilton M, Pearse RM (2013). Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis.. Br J Anaesth, , - . doi:10.1093/bja/aet303
    • Van Der Linden P, James M, Mythen M, Weiskopf RB (2013). In response.. Anesth Analg, 117(2), 530 - 531.
    • Van Der Linden P, James M, Mythen M, Weiskopf RB (2013). In response. Anesthesia and Analgesia, 117(2), 529 - 531. doi:10.1213/ANE.0b013e3182969219
    • Nolan JP, Mythen MG (2013). I. Hydroxyethyl starch: here today, gone tomorrow.. Br J Anaesth, 111(3), 321 - 324. doi:10.1093/bja/aet294
    • Grocott MP, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K, Optimisation Systematic Review Steering Group (2013). Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review.. Br J Anaesth, 111(4), 535 - 548. doi:10.1093/bja/aet155

    2012

    • McMorrow RCN, Windsor JS, Hart ND, Richards P, Rodway GW, Ahuja VY, O'Dwyer MJ, Mythen MG, Grocott MPW (2012). Closed and open breathing circuit function in healthy volunteers during exercise at Mount Everest base camp (5300 m). Anaesthesia, 67(8), 875 - 880. doi:10.1111/j.1365-2044.2012.07152.x
    • Mythen MG (2012). The glycocalyx and colloids: Startling news or sigma by another name?. Journal of the Intensive Care Society, 13(3), 191 - 192.
    • Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MP, James MF, Mythen MG, O'Malley CM, Roche AM, Rowan K (2012). Perioperative buffered versus non-buffered fluid administration for surgery in adults.. Cochrane Database Syst Rev, 12, CD004089 - . doi:10.1002/14651858.CD004089.pub2
    • Wade DM, Howell DC, Weinman JA, Hardy RJ, Mythen MG, Brewin CR, Borja-Boluda S, Matejowsky CF, Raine RA (2012). Investigating risk factors for psychological morbidity three months after intensive care: a prospective cohort study.. Crit Care, 16(5), R192 - . doi:10.1186/cc11677
    • Fawcett WJ, Mythen MG, Scott MJ (2012). Enhanced recovery: more than just reducing length of stay?. Br J Anaesth, 109(5), 671 - 674. doi:10.1093/bja/aes358
    • McMorrow RC, Windsor JS, Hart ND, Richards P, Rodway GW, Ahuja VY, O'Dwyer MJ, Mythen MG, Grocott MP, Caudwell Xtreme Everest Research Group (2012). Closed and open breathing circuit function in healthy volunteers during exercise at Mount Everest base camp (5300 m).. Anaesthesia, 67(8), 875 - 880. doi:10.1111/j.1365-2044.2012.07152.x
    • Sanders JS, Skipworth JR, Cooper JA, Brull DJ, Humphries SE, Mythen M, Montgomery HE (2012). Duration of preceding hypertension is associated with prolonged length of ICU stay.. Int J Cardiol, 157(2), 180 - 184. doi:10.1016/j.ijcard.2010.12.011
    • Grocott MP, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K, Optimisation Systematic Review Steering Group (2012). Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery.. Cochrane Database Syst Rev, 11, CD004082 - . doi:10.1002/14651858.CD004082.pub5
    • Smith GC, Kotwinski P, Sanders J, Cooper J, Ma L, Jones A, Mythen MG, Montgomery HE, Pennell DJ (2012). THE BREAST CANCER, EARLY DISEASE: TOXICITY FROM THERAPY WITH EPIRUBICIN REGIMENS "C CARDIAC ASSESSMENT AND RISK EVALUATION (BETTER-CARE), CARDIOVASCULAR MAGNETIC RESONANCE (CMR) SUB-STUDY: CYCLE 1 CHANGES PREDICT LATE ANTHRACYCLINE CARDIOTOXICITY. doi:10.1136/heartjnl-2012-301877b.18
    • Grocott MP, Martin DS, Mythen MG (2012). Enhanced recovery pathways as a way to reduce surgical morbidity.. Curr Opin Crit Care, 18(4), 385 - 392. doi:10.1097/MCC.0b013e3283558968
    • Martin DS, Pate JS, Vercueil A, Doyle PW, Mythen MG, Grocott MP, Caudwell Xtreme Everest Research Group (2012). Reduced coagulation at high altitude identified by thromboelastography.. Thromb Haemost, 107(6), 1066 - 1071. doi:10.1160/TH12-01-0004
    • Sanders J, Keogh BE, Van der Meulen J, Browne JP, Treasure T, Mythen MG, Montgomery HE (2012). The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery.. J Clin Epidemiol, 65(4), 423 - 433. doi:10.1016/j.jclinepi.2011.11.004
    • Mythen MG, Swart M, Acheson N, Crawford R, Jones K, Kuper M, McGrath JS, Horgan A (2012). Perioperative fluid management: Consensus statement from the enhanced recovery partnership.. Perioper Med (Lond), 1, 2 - . doi:10.1186/2047-0525-1-2
    • Hamilton M, Mythen MG (2012). Welcome to perioperative medicine.. Perioper Med (Lond), 1, 1 - . doi:10.1186/2047-0525-1-1
    • Knott A, Pathak S, McGrath JS, Kennedy R, Horgan A, Mythen M, Carter F, Francis NK (2012). Consensus views on implementation and measurement of enhanced recovery after surgery in England: Delphi study.. BMJ Open, 2(6), - . doi:10.1136/bmjopen-2012-001878

    2011

    • van der Kaaij JM, Martin DS, Grocott MP, Mythen MG (2011). Research on Mount Everest: Exploring adaptation to hypoxia to benefit the critically III patient. Netherlands Journal of Critical Care, 15(5), 240 - 248.
    • Sanders J, Keogh BE, Van Der Meulen J, Browne J, Treasure T, Mythen MG, Montgomery HE (2011). The development and validation of a model to assess total morbidity burden after cardiac surgery. EUROPEAN HEART JOURNAL, 32, 76 - 76.
    • Sanders J, Toor IS, Yurik TM, Keogh BE, Mythen M, Montgomery HE (2011). Tissue oxygen saturation and outcome after cardiac surgery.. Am J Crit Care, 20(2), 138 - 145. doi:10.4037/ajcc2011739
    • Sanders J, Patel S, Cooper J, Berryman J, Farrar D, Mythen M, Montgomery HE (2011). Red blood cell storage is associated with length of stay and renal complications after cardiac surgery.. Transfusion, 51(11), 2286 - 2294. doi:10.1111/j.1537-2995.2011.03170.x
    • Levett DZ, Fernandez BO, Riley HL, Martin DS, Mitchell K, Leckstrom CA, Ince C, Whipp BJ, Mythen MG, Montgomery HE, Grocott MP, Feelisch M, Caudwell Extreme Everest Res Grp (2011). The role of nitrogen oxides in human adaptation to hypoxia. SCI REP-UK, 1, - . doi:10.1038/srep00109
    • Grace C, Kuper M, Weldon S, Lees J, Modasia R, Mythen M (2011). Service redesign. Fitter, faster: improved pathways speed up recovery.. Health Serv J, 121(6255), 28 - 30.
    • Ackland GL, Moran N, Cone S, Grocott MPW, Mythen MG (2011). Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesthesia and Analgesia, 112(6), 1375 - 1381. doi:10.1213/ANE.0b013e3181ee8456
    • McMorrow RC, Windsor JS, Mythen MG, Grocott MP, Caudwell Xtreme Everest Research Group (2011). A novel ambulatory closed circuit breathing system for use during exercise.. Anaesthesia, 66(5), 348 - 353. doi:10.1111/j.1365-2044.2011.06698.x
    • Kehlet H, Mythen M (2011). Why is the surgical high-risk patient still at risk?. Br J Anaesth, 106(3), 289 - 291. doi:10.1093/bja/aeq408
    • Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG (2011). Chronic kidney disease and postoperative morbidity after elective orthopedic surgery.. Anesth Analg, 112(6), 1375 - 1381. doi:10.1213/ANE.0b013e3181ee8456
    • Moonesinghe SR, Mythen MG, Grocott MP (2011). High-risk surgery: epidemiology and outcomes.. Anesth Analg, 112(4), 891 - 901. doi:10.1213/ANE.0b013e3181e1655b
    • Moonesinghe SR, Mythen MG, Grocott MPW (2011). High-risk surgery: Epidemiology and outcomes. Anesthesia and Analgesia, 112(4), 891 - 901. doi:10.1213/ANE.0b013e3181e1655b
    • McMorrow RCN, Windsor JS, Mythen MG, Grocott MPW (2011). A novel ambulatory closed circuit breathing system for use during exercise. Anaesthesia, 66(5), 348 - 353. doi:10.1111/j.1365-2044.2011.06698.x
    • Mythen M (2011). Fit for surgery?. Anesth Analg, 112(5), 1002 - 1004. doi:10.1213/ANE.0b013e318203250f

    2010

    • Ackland GL, Harris S, Ziabari Y, Grocott M, Mythen M, SOuRCe Investigators (2010). Revised cardiac risk index and postoperative morbidity after elective orthopaedic surgery: a prospective cohort study.. Br J Anaesth, 105(6), 744 - 752. doi:10.1093/bja/aeq245
    • Ackland GL, Harris S, Ziabari Y, Mythen M, Grocott M (2010). Revised cardiac risk index and postoperative morbidity after elective orthopaedic surgery: A prospective cohort study. British Journal of Anaesthesia, 105(6), 744 - 752. doi:10.1093/bja/aeq245
    • Hollowell J, Grocott M, Hardy R, Hadad F, Mythen M, Raine R (2010). Major elective joint replacement surgery:socioeconomic variations in surgical risk, postoperative morbidity and length of stay. Journal of Evaluation in Clinical Practice, 16, 529 - 538.
    • Grocott MPW, Martin DS, Wilson MH, Mitchell K, Dhillon S, Mythen MG, Montgomery HE, Levett DZH, Caudwell Xtreme Everest Res Grp (2010). Caudwell Xtreme Everest Expedition. HIGH ALT MED BIOL, 11(2), 133 - 137. doi:10.1089/ham.2009.1093
    • Bennett-Guerrero E, Gan TJ, Roche AM, Mythen MG (2010). Comment on reference to maximum dose for starch.. Anesthesiology, 112(3), 757 - 758. doi:10.1097/ALN.0b013e3181cbd20b
    • Boldt J, Christian Ertmer MD, Frietsch PDT, Gan PTJ, Haljamae PH, Hillmann DR, Holte DK, Kretz PDF-J, Krzanicki DD, Mythen PDMG, Rehberg S, Sakka SG, Stephens DRCM, Stocker PDR, Stover P-DDJF, Suttner PDDS, Tircoveanu R, Aken HV, Linden PPVD, Wahl K, Wappler PDF, Westphal M (2010). Volume Replacement.
    • Edwards LM, Murray AJ, Tyler DJ, Kemp GJ, Holloway CJ, Robbins PA, Neubauer S, Levett D, Montgomery HE, Grocott MP, Clarke K (2010). The effect of high-altitude on human skeletal muscle energetics: P-MRS results from the Caudwell Xtreme Everest expedition. PLoS.One., 5(5), e10681 - .
    • Grocott MP, Martin DS, Wilson MH, Mitchell K, Dhillon S, Mythen MG, Montgomery HE, Levett DZ, Caudwell Xtreme Everest Research Group (2010). Caudwell xtreme Everest expedition.. High Alt Med Biol, 11(2), 133 - 137. doi:10.1089/ham.2009.1093
    • Mythen MM, Burdett E, Stephens RCM, Walker D (2010). Anaesthesiology.
    • Martin DS, Khosravi M, Grocott MPW, Mythen MG (2010). Concepts in hypoxia reborn. CRIT CARE, 14(4), - . doi:10.1186/cc9078
    • Roberts J, Mythen M, Horgan A (2010). Thinking differently: Working to spread enhanced recovery across England. Current Anaesthesia and Critical Care, 21(3), 137 - 141. doi:10.1016/j.cacc.2009.12.003
    • Hollowell J, Hardy R, Raine R, Grocott MPW, Haddad FS, Mythen MG (2010). Major elective joint replacement surgery: Socioeconomic variations in surgical risk, postoperative morbidity and length of stay. Journal of Evaluation in Clinical Practice, 16(3), 529 - 538. doi:10.1111/j.1365-2753.2009.01154.x
    • Grocott MPW, Martin DS, Wilson MH, Mitchell K, Dhillon S, Mythen MG, Montgomery HE, Levett DZH (2010). Caudwell xtreme everest expedition. High Altitude Medicine and Biology, 11(2), 133 - 137. doi:10.1089/ham.2009.1093
    • Martin DS, Khosravi M, Grocott MPW, Mythen MG (2010). Concepts in hypoxia reborn. Critical Care, 14(4), - . doi:10.1186/cc9078
    • Levett DZ, Martin DS, Wilson MH, Mitchell K, Dhillon S, Rigat F, Montgomery HE, Mythen MG, Grocott MP, Caudwell Xtreme Everest Research Group (2010). Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia.. BMC Med Res Methodol, 10, 98 - . doi:10.1186/1471-2288-10-98

    2009

    • Grocott MP, Martin DS, Levett DZ, McMorrow R, Windsor J, Montgomery HE (2009). Arterial blood gases and oxygen content in climbers on Mount Everest. N.Engl.J.Med., 360(2), 140 - 149.
    • Moonesinghe SR, Mythen MG, Grocott MP (2009). Patient-related risk factors for postoperative adverse events.. Curr Opin Crit Care, 15(4), 320 - 327. doi:10.1097/MCC.0b013e32832e067c
    • Mythen MG (2009). Postoperative gastrointestinal tract dysfunction: an overview of causes and management strategies.. Cleve Clin J Med, 76 Suppl 4, S66 - S71. doi:10.3949/ccjm.76.s4.11
    • Mythen M (2009). Pre-operative coronary revascularisation before non-cardiac surgery: think long and hard before making a pre-operative referral.. Anaesthesia, 64(10), 1048 - 1050. doi:10.1111/j.1365-2044.2009.06056.x
    • Martin DS, Levett DZH, Mythen M, Grocott MPW (2009). Changes in skeletal muscle oxygenation during exercise measured by near-infrared spectroscopy on ascent to altitude. Critical Care, 13, - .
    • Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA (2009). Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.. Circulation, 120(1), 21 - 27. doi:10.1161/CIRCULATIONAHA.108.834275
    • Sanders J, Toor I, Yurik T, Smith A, Keogh BE, Montgomery HE, Mythen M (2009). A simple measure to reduce the incidence of heparin induced thrombocytopenia (HIT) in cardiac intensive care patients - a retrospective observational analysis. doi:10.1111/j.1365-2044.2008.05748_3.x
    • Martin DS, Levett DZ, Mythen M, Grocott MP, Caudwell Xtreme Everest Research Group (2009). Changes in skeletal muscle oxygenation during exercise measured by near-infrared spectroscopy on ascent to altitude.. Crit Care, 13 Suppl 5, S7 - . doi:10.1186/cc8005
    • Moonesinghe SR, Mythen MG, Grocott MP (2009). Patient-related risk factors for postoperative adverse events. Curr Opin Crit Care, 15(4), 320 - 327.
    • Powell-Tuck J, Gosling P, Lobo DN, Carlson GL, Allison SP, Gore M, Lewington AJ, Pearse RL, Mythen MG (2009). Intravenous fluids in surgery Authors of guideline respond. BRIT MED J, 339, - . doi:10.1136/bmj.b3030

    2008

    • Broadhead M, Mythen M (2008). Monitoring. In Bingham R, Lloyd-Thomas A, Sury M (Ed.), Hatch & Sumner's Textbook of Paediatric Anaesthesia (pp. 295 - 311). : Hodder Arnold.
    • Mythen M (2008). Low Volume versus High Volume Resuscitation in Trauma. In Ridley S (Ed.), Critical Care Focus (pp. 181 - 188). : The Intensive Care Society.
    • Sanders J, Martin D, Smith A, Keogh B, Mutch M, Hamilton M, Montgomery H, Mythen M (2008). Tissue oxygen saturation during anaesthesia, cardiopulmonary bypass and intensive care stay for cardiac surgery.
    • Grocott M, Martin D, Levett D, Montgomery H, Mythen M (2008). Caudwell Xtreme Everest. Anaesthesia and Analgesia, Suppl 106(4), 81 - 84.
    • Ackland GL, Harrington J, Downie P, Holding JW, Singh-Ranger D, Griva K, Mythen MG, Newman SP (2008). Dehydration induced by bowel preparation in older adults does not result in cognitive dysfunction.. Anesth Analg, 106(3), 924 - 929. doi:10.1213/ane.0b013e3181615247

    2007

    • Grocott MP, Browne JP, Van der Meulen J, Matejowsky C, Mutch M, Hamilton MA, Levett DZ, Emberton M, Haddad FS, Mythen MG (2007). The Postoperative Morbidity Survey was validated and Used to Describe Morbidity after Major Surgery. Journal of Clinical Epidemiology, 60(9), 919 - 928. doi:10.1016/j.jclinepi.2006.12.003
    • Grocott MPW, Levett DZH, Matejowsky C, Emberton M, Mythen MG (2007). ASA scores in the pre-operative patient: feedback to clinicians can improve data quality. Journal of Evaluation in Clinical Practice, 13(2), 318 - 319.
    • Ackland GL, Mythen MG (2007). Novel biomarkers in critical care: utility or futility?. Crit Care, 11(6), 175 - . doi:10.1186/cc6127
    • Martin DS, Dick J, Grocott M, Mccorkell S, Vercueil A, Gunning P, Cox M, Mythen M (2007). Increased gastric-end tidal P gap during exercise at high altitude measured by gastric tonometry. High Altitude Medicine and Biology, 8(1), 50 - 55. doi:10.1089/ham.2006.1022
    • Ackland GL, Scollay JM, Parks RW, de B, I M, M G (2007). Pre-operative high sensitivity C-reactive protein and postoperative outcome in patients undergoing elective orthopaedic surgery. Anaesthesia, 62(9), 888 - 894.
    • Grocott M, Richardson A, Montgomery H, Mythen M (2007). Caudwell Xtreme Everest: a field study of human adaptation to hypoxia. Critical Care, 11(4), 151 - 152.
    • Van Zundert AAJ, Mythen MC, Kerkkamp HEM, Mortier EP (2007). Is there a colloideal solution? - Part II. CPD Anaesthesia, 9(1), 43 - 57.
    • Ackland G, Mythen M (2007). Physiology of the Gastrointestinal Tract Including Splanchnic Blood Flow and Tonometry. In Kumar CM, Bellamy M (Ed.), Gastrointestinal and colorectal anesthesia (pp. 1 - 12). : Informa Healthcare USA Inc..
    • Mythen M, Soni N (2007). Industry Sponsorship. In Ridly S (Ed.), Critical Care Focus (pp. 94 - 110). : The Intensive Care Society.
    • (2007). Increased gastric-end tidal PCO2 gap during exercise at high altitude: a tonometric study. High Altitude Medicine and Biology, 8(1), 50 - 55.
    • van Zundert AAJ, Mythen M, Kerkkamp HEM, Mortier EP (2007). Volume Therapy; Is there a colloideal solution? - Part II. CPD Anaesthesia, 9(1), 43 - 57.
    • Martin D, McCorkell S, Vercueil A, Gunning P, Cox M, Dick J, Mythen M, Grocott M (2007). Increased gastric-end tidal P(CO2) gap during exercise at high altitude measured by gastric tonometry.. High Alt Med Biol, 8(1), 50 - 55. doi:10.1089/ham.2006.1022
    • Usher SM, Walker DA, Mythen MG (2007). Doppler cardiac output monitoring: a tool for all physicians.. Br J Hosp Med (Lond), 68(3), 126 - 130.

    2006

    • Mythen MG, Curran N (2006). Dysfonction gastro-intestinale postopératoire: Épidé miologie et traitement. Praticien en Anesthesie Reanimation, 10(3), 166 - 172.
    • Grocott MPW, Mythen MG, Gan TJ (2006). In response [20]. Anesthesia and Analgesia, 102(2), 652 - 652. doi:10.1213/01.ANE.0000190766.86657.11
    • Mythen M, Vercueil A (2006). End Points for Volume Resuscitation. In Goldhill D (Ed.), Current Orthopaedic Anaesthesia and Critical Care (pp. 61 - 69). : KKS Printing.
    • Roche AM, James MF, Bennett-Guerrero E, Mythen MG (2006). Calcium supplementation of saline-based colloids does not produce equivalent coagulation profiles to similarly balanced salt preparations.. J Cardiothorac Vasc Anesth, 20(6), 807 - 811. doi:10.1053/j.jvca.2006.03.006
    • van Zundert AAJ, Mythen MC, Kerkkamp HEM, Mortier EP (2006). Volume therapy: Is there a colloïdeal solution?. CPD Anaesthesia, 8(3), 131 - 149.
    • McMorrow RC, Mythen MG (2006). Pulse oximetry. CURR OPIN CRIT CARE, 12(3), 269 - 271.
    • Mythen M, Hamilton MA (2006). Oesophageal Doppler Monitoring. In Allman KG, Wilson IH (Ed.), Oxford Handbook of Anaesthesia (pp. 984 - 988). : Oxford University Press.
    • Hamilton MA, Mythen MG, Ackland GL (2006). Less is not more: a lack of evidence for intraoperative fluid restriction improving outcome after major elective gastrointestinal surgery. Anesthesia and Analgesia, 102(3), 970 - 971.
    • Stephens RC, Fidler K, Wilson P, Barclay GR, Mythen MG, Dixon GL, Turner MW, Klein NJ, Peters MJ (2006). Endotoxin immunity and the developmentof the systemic inflammatory responsesyndrome in critically ill children. Intensive Care Medicine, 32(2), 286 - 294.
    • Grocott MPW, Mythen MG, Gan TJ (2006). Differentiating "volumetric preload monitoring" and assessing "fluid responsiveness" - In response. ANESTH ANALG, 102(2), 652 - 652.
    • Roche AM, James MF, Grocott MP, Mythen MG (2006). Just scratching the surface: varied coagulation effects of polymer containers on TEG variables. European Journal of Anaesthesiology, 23(1), 45 - 49.
    • McCorkell S, Grocott M, Martin M, Cox M, Dick J, Gunning P, Vercueil A, Mythen M (2006). Gasrtic Tonometry at rest and during exercise at 5100m. 2006;:().
    • Mythen M, Walker D, Self R (2006). Blood Products and Fluid Therapy. In Allman KG, Wilson IH (Ed.), Oxford Handbook of Anaesthesia (pp. 1001 - 1024). : Oxford University Press.
    • Roche AM, James MF, Bennett-Guerrero E, Mythen MG (2006). A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesthesia and Analgesia, 102(4), 1274 - 1279.

    2005

    • Mythen MG (2005). Fluid balance in the critically ill. Acta Medica Croatica, 59(SUPPL. 1), 9 - 10.
    • Scollay JM, Parks RW, Mythen M, deBeaux I (2005). Use of critical care beds in a Scottish teaching hospital following major surgery (vol 93, pg 317, 2004). BRIT J ANAESTH, 94(1), 141 - 141. doi:10.1093/bja/aei042
    • Coakley M, Self R, Marchant W, Mackie I, Mallett SV, Mythen M (2005). Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease. Anaesthesia, 60(12), 1173 - 1178. doi:10.1111/j.1365-2044.2005.04291.x
    • Ackland GL, Mythen MG (2005). Negative pressure pulmonary edema as an unsuspected imitator of acute lung injury/ARDS. Chest, 127(5), 1867 - 1868.
    • Mythen MG (2005). Saline induced acidosis: Is it clinically relevant?.
    • Stephens R, Rashid M, Dixon G, Baxendale H, Mythen M (2005). Do levels of antibody to endotoxin core change with time?.
    • Ackland GL, Scollay J, Parks RW, DeBeaux I, Mythen M (2005). High-sensitivity C reactive protein correlates with length of hospital stay but not myocardial ischemia or morbidity in orthopaedic patients.
    • Bennett D, Chaloner E, Emberton M, Garfield M, Grocott MP, Mythen MG (2005). Modernising Care for Patients Undergoing Major Surgery: Improving Patient Outcomes & Increasing Clinical Efficiency. A report by the Improving Surgical Outcomes Group 2005..
    • Stephens R, Rashid M, Dixon G, Baxendale H, Mythen M (2005). Do levels of antibody to endotoxin core change with time?. Shock, 23, 189 - .
    • Burdett E, Mythen M (2005). Putting in central venous lines. BR J HOSP MED (LOND), 66(9), M36 - M38.
    • Burdett E, Mythen M (2005). Putting in central venous lines. HOSP MED, 66(9), M36 - M38.
    • Hamilton MA, Chapman MV, Mutch M, Bennett-Guerrero E, Mythen MG (2005). The relationship between a pentagastrin-stimulated gastric luminal acid production test (Gastrotest) and enteral feeding-related gastrointestinal complications in critically ill patients. Anesthesia and Analgesia, 100(5), 1447 - 1452. doi:10.1213/01.ANE.0000148688.30121.C0
    • Grocott MP, Mythen MG, Gan TJ (2005). Perioperative fluid management and clinical outcomes in adults. Anesthesia and Analgesia, 100(4), 1093 - 1106.
    • Vercueil A, Grocott MP, Mythen MG (2005). Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfusion Medicine Reviews, 19(2), 93 - 109.
    • Ackland GL, Scollay J, Parks RW, DeBeaux I, Mythen M (2005). Preoperative high sensitivity-C reactive protein and cardiac risk scoring systems.
    • Ackland GL, Scollay J, Parks RW, DeBeaux I, Mythen M (2005). ASA / AHA cardiac risk score and morbidity in orthopedic patients.
    • Hamilton MA, Pate JS, Luery H, Mythen M, Ackland GL (2005). Metabolic changes following standardized handgrip exercise correlate with global anaerobic threshold.
    • Dick J, Ross G, McCorkell S, Mythen MG (2005). The effect of acute hypoxia on coagulation in healthy subjects.
    • Luery H, Usher S, Walker D, Mythen M (2005). Supra-Sternal doppler for the assessment of cardiac output during exercise.
    • Mythen MG (2005). Fluid Balance in the critically ill.
    • Mythen MG (2005). Postoperative gastrointestinal tract dysfunction. Anesthesia and Analgesia, 100(1), 196 - 204.
    • Stephens RCM, Dixon G, Rashid M, Mythen MG (2005). Anti-endotoxin therapies: where are we now?. Netherlands Journal of Critical Care, 9, 20 - 25.
    • Stephens R, Rashid M, Dixon G, Baxendale H, Mythen M (2005). How do levels of antibody against endotoxin core change with time?.
    • Stephens RCM, O'Malley CMN, Frumento RJ, Mythen MG, Bennett-Guerrero E (2005). Low-dose endotoxin elicits variability in the inflammatory response in healthy volunteers. Journal of Endotoxin Research, 11(4), 207 - 212.

    2004

    • Mythen M, Vercueil A (2004). ES06.03 Fluid balance. Vox Sanguinis, 87(SUPPL.1), 77 - 81. doi:10.1111/j.1741-6892.2004.00436.x
    • Grocott MPW, Chaloner E, Mythen MG, Mackenzie SJ, Older P, Hall A (2004). Should perioperative management target oxygen delivery? (multiple letters) [1]. British Journal of Anaesthesia, 92(4), 597 - 598. doi:10.1093/bja/aeh540
    • Self R, Mackie I, Jenkins A, Sanders J, Williams A, Machin S, Mythen M (2004). Use of the Thrombelastograph (R) to assess the in vitro effects of DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass.
    • Luery H, Meeran H, Chaloner E, Montgomery H, Mythen M (2004). Changes in anaerobic threshold following 12 h nil by mouth in healthy volunteers: pilot data.
    • Scollay JM, Parks RW, Mythen M, deBeaux I (2004). Use of critical care beds in a Scottish teaching hospital following major surgery.
    • Aurora P, Stocks J, Oliver C, Saunders C, Castle R, Chaziparasidis G, Bush A (2004). Quality control for spirometry in preschool children with and without lung disease. American Journal of Respiratory and Critical Care Medicine, 169(10), 1152 - 1159. doi:10.1164/rccm.200310-1453OC
    • Singh-Ranger D, Ackland G, Mythen M, Boulos PB (2004). Bowel preparation causes hypercoagulability in females.
    • Singh-Ranger D, Ackland G, Mythen M, Boulos PB (2004). Bowel preparation causes hypercoagulability in females.
    • Self R, Mackie IJ, Williams AM, Jenkins AMC, Mythen MG (2004). Activated thrombelastograph reaction (r) time is contact factor dependent and prolonged by DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass.
    • Self R, Mythen MG (2004). Volume replacement in the elderly. In Boldt J (Ed.), Volume Replacement (pp. 66 - 72). : Uni-Med.
    • Mythen MG (2004). Transfusion Alternatives in Transfusion Medicine: Editorial. Transfusion Alternatives in Transfusion Medicine, 5, 375 - 376.
    • Grocott MPW, Chaloner E, Mythen MG (2004). Should perioperative management target oxygen delivery?. British journal of Anaesthesia, 92(4), 597 - 598.
    • Roche AM, Mythen MG, James MFM (2004). Effects of a new modified balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. BRIT J ANAESTH, 92(1), A154 - 155. doi:10.1093/bja/aeh502
    • Hamilton-Davies C, Mythen M, O'Malley C (2004). Endotoxaemia during left ventricular assist device insertion (multiple letters) [6]. British Journal of Anaesthesia, 92(6), 907 - 907.
    • James MF, Latoo MY, Mythen MG, Mutch M, Michaelis C, Roche AM, Burdett E (2004). Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers. Anaesthesia, 59(8), 738 - 742.
    • Mythen M, Vercueil A (2004). Fluid balance. Vox Sanguinis, 87 Suppl1(Supp 1), 77 - 81.
    • Hamilton-Davies C, Mythen M (2004). Endotoxaemia during left ventricular assist device insertion. BRIT J ANAESTH, 92(6), 907 - 907. doi:10.1093/bja/aeh562
    • Ackland GL, Singh-Ranger D, Fox S, McClaskey B, Down J, Farrar D, Sivaloganathan M, Mythen MG (2004). Assessment of preoperative fluid depletion using bioimpedence analysis. British Journal of Anaesthesia, 92(1), 134 - 136.
    • Ajitsaria R, Awad WI, Jaffe A, Sheppard MN, Goldstraw P, Hansell D, Bush A (2004). Case for diagnosis: Congenital lung abnormality in a one year old. European Respiratory Journal, 23(2), 348 - 352.
    • Burdett E, Roche A, Mythen MG (2004). Hyperchloremic acidosis: Pathophysiology and clinical impact. Transfusion Alternatives in Transfusion Medicine, 5, 424 - 430.
    • Down J, Barclay R, Bennett-Guerrero E, Hamilton-Davies C, Stephens R, Grocott MPW, Mythen MG (2004). Descriptive study of the variation in baseline levels of anti-endotoxin core antibodies between US and UK populations. Journal of Endotoxin Research, 10, 195 - 196.
    • Lebuffe G, Vallet B, Takals J, Lamy M, Harstein G, Mythen MG, Bakker J, Bennet D, Bovd O, Webb A (2004). European multi-centre observational study to assess the value of gastric mucosal-end tidal PC02 difference in predicting post-operative complications. Anesthesia and Analgesia, 99, 166 - 172.
    • Roche A, Mythen MG, James MF (2004). Effects of a new modified balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. British Journal of Anaesthesia, 92(1), 154 - 155.
    • Roche A, Med M, Hoare G, Wilbourne B, Royston D, Mythen MG (2004). Crystalloids and colloid hydroxyethyl starch solutions do not change GPIb or P-Selectin function of platelets.
    • Campbell AM, Mythen MG (2004). Gastrointestinal complications. In Mackay JH, Arrowsmith JE (Ed.), Core Topics in Cardiac Anaesthesia (pp. 303 - 306). : Greenwich Medical Media.

    2003

    • Parry-Jones AP, Hamilton N, Mythen MG (2003). Systolic pressure variability versus right atrial pressure to monitor a virtual fluid challenge.
    • Parry-Jones AP, Hamilton N, Mythen MG (2003). Systolic pressure variability versus right atrial pressure to monitor a virtual fluid challenge.
    • Roche AM, James MFM, Grocott MPW, Mythen MG (2003). Citrated blood does not reliably reflect fresh whole blood coagulability in trials of in vitro hemodilution. ANESTH ANALG, 96(1), 58 - 61. doi:10.1213/01.ANE.0000040005.95838.57
    • Wyncoll D, Mythen MG (2003). Should activated protein C be given to a patient who has an epidural?. Hospital Medicine, 64, 692 - .
    • Stephens R, Mythen MG (2003). Update on anti-endotoxin therapies. In (Ed.), Brussels Yearbook of Intensive Medicine (pp. - ). : .
    • Stephens R, Mythen MG (2003). Resus fluids and hyperchloraemic metabolic acidosis. Trauma, 5, 1 - 7.
    • Mythen MG (2003). Hyperchloremic Acidosis: pathophysiology and clinical impact. Transfusion Alternatives in Transfusion Medicine, 5(1 Supp), 33 - 35.
    • Mythen MG (2003). Colloids and blood products. In Bersten AD, Soni N, Oh TE (Ed.), Oh's Intensive Care Manual (pp. 927 - 932). : Butterworth, Heinemann.
    • Mythen MG (2003). A case of US and them. Health Service Journal, 113, 18 - 19.
    • Bennett-Guerrero E, Hyam JA, Shaefi S, Prytherch DR, Sutton GL, Weaver PC, Mythen MG, Grocott MPW, Parides MK (2003). Comparison of P-POSSUM risk-adjusted mortality rates after surgery between patients in the United States of America and the United Kingdom. British Journal of Surgery, 90(12), 1593 - 1598.
    • Bakker J, Imhoff M, Ludgate S, Mythen MG, Nightingale P, Takala J, Waldmann C, Webb A (2003). RP423.
    • Bennett-Guerrero E, Hyam JA, Shaefi S, Prytherch DR, Sutton GL, Weaver PC, Mythen MG, Grocott MP, Parides MK (2003). Comparison of P-POSSUM risk-adjusted mortality rates after surgery between patients in the USA and the UK.. Br J Surg, 90(12), 1593 - 1598. doi:10.1002/bjs.4347
    • Bennett-Guerrero E, Parides MK, Hyam JA, Shaefi S, Mythen MG, Grocott MP, Prytherch DR, Sutton GL, Weaver PC (2003). Comparison of P-POSSUM risk-adjusted mortality rates after surgery between patients in the USA and the UK. British Journal of Surgery, 90(12), 1593 - 1598. doi:10.1002/bjs.4347
    • Stephens R, Mythen M (2003). Resuscitation fluids and hyperchloraemic metabolic acidosis. Trauma, 5(2), 141 - 147. doi:10.1191/1460408603ta279oa
    • (2003). Should activated protein C be given to a patient who has an epidural? (Editorial). Hospital Medicine, 64(11), 692 - .
    • Stephens R, Mythen MG (2003). Optimising intraoperative fluid therapy. Current Opinion in Anaesthesiology, 16(4), 385 - 392.
    • Roche A, James MF, Grocott MPW, Mythen MG (2003). Citrated blood does not reliably reflect fresh whole blood coagulability in trials of in vitro hemodilution. Anesthesia and Analgesia, 96(1), 58 - 61. doi:10.1097/00000539-200301000-00012

    2002

    • Parekh N, Wilkes NJ, Mallett SV, Mythen MG (2002). Hyperchloremic acidosis [7] (multiple letters). Anesthesia and Analgesia, 95(6), 1821 - 1822.
    • Martin G, Bennett-Guerrero E, Wakeling H, Mythen MG, El Moalem H, Robertson K, Kucmeroski D, Gan TJ (2002). A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. Journal of Cardiothoracic and Vascular Anesthesia, 16, 441 - 446.
    • Wilkes NJ, Woolf RL, Powanda MC, Gan TJ, MacHin SJ, Webb A, Mutch M, Bennett-Guerrero E, Mythen MG (2002). Hydroxyethyl starch in balanced electrolyte solution (Hextend)-- pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesthesia and Analgesia, 94(3), 538 - 544.
    • Burdett E, Roche A, Fong K, Grocott MPW, Mythen MG (2002). A systematic review of buffered versus non-buffered perioperative fluid resuscitation and urine output.
    • (2002). The effects of fluid optimization on outcome following major surgery. Transfusion Alternatives in Transfusion Medicine, 4, 74 - 79.
    • Welsby IJ, Bennett-Guerrero E, Atwell D, White WD, Newman MF, Smith PK, Mythen MG (2002). The association of complication type with mortality and prolonged stay after cardiac surgery with cardiopulmonary bypass. Anesthesia and Analgesia, 94(5), 1072 - 1078.
    • Wilkes NJ, Woolf RL, Powanda MC, Gan TJ, Machin SJ, Webb A, Mutch M, Bennett-Guerrero E, Mythen M (2002). Hydroxyethyl starch in balanced electrolyte solution (Hextend)--pharmacokinetic and pharmacodynamic profiles in healthy volunteers.. Anesth Analg, 94(3), 538 - 544.
    • Adams MJ, Cardigan RA, Marchant WA, Grocott MPW, Mythen MG, Mutch M, Purdy G, MacKie IJ, MacHin SJ (2002). Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, 16(1), 59 - 63.
    • (2002). The effect of hypothermia on calculated values using saline and automated air tonometry. Journal of Cardiothoracic and Vascular Anesthesia, 16(3), 304 - 307.
    • Fong K, Roche A, Burdett E, Mythen MG (2002). Meta-analysis of estimated peri-operative blood loss for buffered versus non-buffered IV fluid resuscitation.
    • Wilkes NJ, Mallett SV, Mythen MG (2002). Hyperchloremic acidosis - Response. ANESTH ANALG, 95(6), 1821 - 1822.
    • (2002). Hyperchloremic acidosis. Anesthesia and Analgesia, 95(6), 1821 - 1822.
    • (2002). Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution. Anaesthesia, 57(10), 950 - 955.
    • Rashid M, Siva M, Burdett E, Mythen MG (2002). Regional variation in anti-endotoxin core antibody titres in donors.

    2001

    • Bennett-Guerrero E, Panah MH, Barclay R, Bodian CA, Winfree WJ, Andres LA, Reich DL, Mythen MG (2001). Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery. Anesthesiology, 94(6), 992 - 997. doi:10.1097/00000542-200106000-00012
    • Hurley R, Grocott MPW, Siva M, Goldsack C, Frossard J, Mythen MG (2001). Tonometry-guided therapy: An algorithm-testing pilot study.
    • (2001). Two episodes in the same patient of life-threatening anaphylaxis to a chlorhexidine-sulphadiazine-coated central venous catheter. British Journal of Anaesthesia, 87(2), 306 - 308.
    • Roche AM, James MF, Grocott MP, Mythen MG (2001). Method of citrate storage of fresh blood affects whole blood coagulation.
    • (2001). Gastric tonometry: Where do we stand?. Current Opinion in Critical Care, 7, 122 - 127.
    • (2001). Fluid therapy in septic shock (Review). Sepsis, 4, 109 - 122.
    • Grocott MP, Roche AR, James MF, Chapman MV, Mythen MG (2001). Container type affects in vitro coagulation assessment after hemodilution.
    • (2001). Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Archives of Surgery, 136(10), 1173 - 1183.
    • (2001). Endotoxin-neutralizing capacity of serum from cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia, 15(4), 451 - 454.
    • Ackland GL, McClaskey B, Farrar D, Grocott MP, Mythen M (2001). Establishing a body weight/bioimpedance model to assess relative pre-operative dehydration in ambulatory surgical patients.
    • Stephens R, Mythen M, Kallis P, Davies DW, Egner W, Rickards A (2001). Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter.. Br J Anaesth, 87(2), 306 - 308.
    • Bennett-Guerrero E, Feierman DE, Barclay GR, Parides MK, Sheiner PA, Mythen MG, Levine DM, Parker TS, Carroll SF, White ML, Winfree WJ (2001). Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation.. Arch Surg, 136(10), 1177 - 1183.
    • Matejowsky C, Grocott MP, Pearson S, Emberton M, Mythen M (2001). Do you trust the ASA score on your clinical database?.
    • (2001). The National Confidential Enquiry into Perioperative Deaths 2000: Then and now. Hospital Medicine, 62(5), 262 - 263.
    • Pearson S, Grocott MP, Matejowsky C, Emberton M, Mythen M (2001). Is there a skew loose in your clinical database?.
    • Grocott MPW, Mythen MG (2001). Fluid administration in septic shock. Sepsis, 4(2), 111 - 124. doi:10.1023/A:1011450703625
    • (2001). The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. British Journal of Anaesthesia, 93(4), 811 - 816.

    2000

    • (2000). Endotoxin immunization. Intensive Care Medicine, 26 (Su, S129 - S136.
    • (2000). Saline-based fluids can cause a significant acidosis that may be clinically relevant. Critical Care Medicine, 28(9), 3375 - 3377.
    • Wilkes NJ, Stephens R, Woolf R, Mallett SV, Mythen MG (2000). Randomized controlled trial of balanced versus sodium chloride based intravenous solutions in the elderly surgical patient. Anesthesiology, 93(3A), A175 - .
    • (2000). Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine. Infection and Immunity, 68(11), 6202 - 6208.
    • (2000). Gastrointestinal tonometry: State of the art. Intensive Care Medicine, 26, 613 - 622.
    • (2000). Current status of gastrointestinal tonometry. Current Opinion in Critical Care, 6, 130 - 135.
    • Hurley R, Grocott M, Mythen MG (2000). In vitro validation of the Tonocap and a modified Paratrend 7 sensor.
    • (2000). The Haldane effect - An explanation for increasing gastric mucosal PCO2 gradients?. British Journal of Anaesthesia, 85(1), 167 - 169.
    • Levett DZH, Mythen MG, Emberton M, Grocott MPW (2000). Quality data - A prerequisite for assessing quality of care.
    • Stephens RCM, Mythen MG, Waters J (2000). Saline-based fluids can cause a significant acidosis that may be clinically relevant [7] (multiple letters). Critical Care Medicine, 28(9), 3375 - 3377.
    • Haynes GR, Bailey MK, Gan TJ, Benneth-Guerrero E, Mythen MG (2000). Excessive use of hetastarch: An iatrogenic cause of bleeding and hypocalcemia? [2] (multiple letters). Anesthesia and Analgesia, 90(6), 1455 - 1456.
    • Wilkes NJ, Stephens R, Woolf R, Mallett SV, Mythen MG (2000). Randomized controlled trial of balanced versus sodium chloride based intravenous solutions in the elderly surgical patient. ANESTHESIOLOGY, 93(3A), U136 - U136.
    • Roche AM, Grocott MPW, Mythen MG, James MFM (2000). In vitro serial haemodilution with a balanced electrolyte hetastarch solution (Hextend) and TEG analysis. ANESTHESIOLOGY, 93(3A), U137 - U137.
    • Bennett-Guerrero E, McIntosh TJ, Barclay GR, Mythen MG, Poxton IR (2000). Preparation and preclinial evaluation of a novel liposomal complete-core lipopolysaccharide vaccine. ANESTHESIOLOGY, 93(3A), U160 - U160.
    • Gan TJ, Bennett-Guerrero E, Mythen MG (2000). Excessive use of hetastarch: An iatrogenic cause of bleeding and hypocalcemia? In response. ANESTH ANALG, 90(6), 1456 - 1456.
    • Chapman MV, Mythen MG, Webb AR, Vincent JL (2000). Report from the meeting: Gastrointestinal Tonometry: State of the Art. 22nd-23rd May 1998, London, UK.. Intensive Care Med, 26(5), 613 - 622.
    • (2000). Understanding gastrointestinal perfusion in critical care: So near, and yet so far. Critical Care, 4(5), 269 - 281.
    • (2000). Automated detection of gastric luminal partial pressure of carbon dioxide during cardiovascular surgery using the Tonocap. Anesthesiology, 92(1), 38 - 45.
    • (2000). Comparison of the response of saline tonometry and an automated gas tonometry device to a change in CO2. Critical Care Medicine, 28(11), 3728 - 3733.

    1999

    • Grocott MPW, Mythen MG (1999). Fluid therapy. Bailliere's Best Practice in Clinical Anaesthesiology, 13(3), 363 - 381. doi:10.1053/bean.1999.0024
    • Grocott M, Hamilton-Davies C, Barclay GR, Calvano S, Lowry S, Bennett-Guerrero E, Mythen MG (1999). Variation of endogenous endotoxin immunity between UK and US surgical patients. BRIT J ANAESTH, 82, 170 - 171.
    • Mythen M, Clutton-Brock T (1999). The oxygen trail: measurement.. Br Med Bull, 55(1), 109 - 124.
    • Grocott MPW, Mythen MG (1999). Fluid Therapy. in: The High Risk Surgical Patient. Bailliere’s Clinical Anaesthesiology, 13(3), 363 - 381.
    • Chapman M, Woolf RL, Mutch M, Mythen MG (1999). Temperature-dependent errors using gastrointestinal tonometry - an in vitro study. BRIT J ANAESTH, 82(5), 787P - 788P.
    • Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PS, Machin SJ, Mythen MG (1999). Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group.. Anesth Analg, 88(5), 992 - 998.
    • Hamilton-Davies C, Barclay R, Stidwell R, Rosser D, Singer M, Grocott M, Mythen M (1999). Sterile bred rats for studies involving endotoxin challenges have differing levels of endogenous immunity to endotoxin core. BRIT J ANAESTH, 82, 180 - 180.
    • Woolf RL, Chapman MV, Mutch M, Mythen MG (1999). Hyperamylasaemia associated with the use of a new Hydroxyethyl Starch (HES) - Hextend (R). BRIT J ANAESTH, 82, 76 - 77.
    • Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, Phillips-Bute BG, Newman MF, Mythen MG (1999). The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery.. Anesth Analg, 89(2), 514 - 519.
    • Mythen M (1999). Dopexamine protects the gut mucosa during major surgery?. Crit Care Med, 27(9), 2038 - 2039.
    • Gan TJ, Bennett-Guerrero E, Phillips-Bute B, Wakeling H, Moskowitz DM, Olufolabi Y, Konstadt SN, Bradford C, Glass PSA, Machin SJ, Mythen MG, Hextend Study Grp (1999). Hextend (R), a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial.
    • Woolf RL, Chapman MV, Mythen MG (1999). Early clinical experience with a newly formulated hydroxyethyl starch--Hextend.. Br J Anaesth, 82(2), 299 - 300.
    • Chapman MV, Woolf RL, Mutch M, Mythen MG (1999). Temperature dependent errors using gastrointestinal tonometry: an in vivo study. BRIT J ANAESTH, 82, 174 - 174.
    • Martin G, El-Moalem H, Bennett-Guerrero E, Mythen MG, Gan TJ (1999). Comparison of intraoperative blood loss in patients undergoing major surgery using Hextend, Hespan and lactated Ringer's solution.. ANESTHESIOLOGY, 91(3A), U158 - U158.
    • Gan TJ, Moretti E, El-Moalem H, Mythen MG, Glass PSA (1999). Intraoperative colloid administration improves the quality of patient recovery after surgery. ANESTHESIOLOGY, 91(3A), U453 - U453.

    1998

    • Woolf RL, Mythen MG (1998). Con: heparin-bonded cardiopulmonary bypass circuits do not represent a desirable and cost-effective advance in cardiopulmonary bypass technology.. J Cardiothorac Vasc Anesth, 12(6), 710 - 712.
    • Mythen MG, Woolf R, Noone RB (1998). Gastric mucosal tonometry: towards new methods and applications.. Anasthesiol Intensivmed Notfallmed Schmerzther, 33 Suppl 2, S85 - S90. doi:10.1055/s-2007-994883
    • Bennett-Guerrero E, Devine P, Panah MH, Methikalam BJ, Alfarone JR, DePerio M, Mythen MG (1998). Automated detection of gastric mucosal hypoperfusion during cardiovascular surgery using the Tonocap (TM). ANESTHESIOLOGY, 89(3A), U838 - U838.
    • Gan TJ, Glass PSA, Robertson K, El-Moalem H, Hilton AB, Kucmeroski D, Dufore S, Mythen MG, Hextend Study Grp (1998). The effects of Hextend (R) and Hespan (R) on thromboelastography. ANESTHESIOLOGY, 89(3A), U809 - U809.
    • Bennett-Guerrero E, Mythen MG (1998). Could we know epsilon-aminocaproic acid level during cardiopulmonary bypass? Response. ANESTH ANALG, 86(3), 680 - 681.
    • Celebioglu B, Benneth-Guerero E, Mythen MG (1998). Could we know ε-aminocaproic acid level during cardiopulmonary bypass? [12] (multiple letters). Anesthesia and Analgesia, 86(3), 680 - 681.
    • Noone RB, Mythen MG, Vaslef SN (1998). Effect of alpha(alpha)-cross-linked hemoglobin and pyridoxalated hemoglobin polyoxyethylene conjugate solutions on gastrointestinal regional perfusion in hemorrhagic shock.. J Trauma, 45(3), 457 - 469.
    • Mythen MG, Webb AR (1998). Gastrointestinal tonometry comes of age?. Br J Anaesth, 81(5), 667 - 668.
    • Gan TJ, Bennett-Guerrero E, Glass PSA, Moskowitz DM, Robertson K, Phillips-Bute B, Konstadt S, Hilton AB, Kuemeroski D, Dufore S, Mythen MG, Hextend Study Grp (1998). Comparison of intraoperative administration of Hextend (R) vs. Hespan (R) for the treatment of hypovolemia during major surgery. ANESTHESIOLOGY, 89(3A), U289 - U289.

    1997

    • Croughwell ND, Newman MF, Lowry E, Davis RD, Landolfo KP, White WD, Kirchner JL, Mythen MG (1997). Effect of temperature during cardiopulmonary bypass on gastric mucosal perfusion.. Br J Anaesth, 78(1), 34 - 38.
    • Lubarsky DA, Glass PSA, Ginsberg B, Dear GD, Dentz ME, Gan TJ, Sanderson IC, Mythen MG, Dufore S, Pressley CC, Gilbert WC, White WD, Alexander ML, Coleman RL, Rogers M, Reves JG (1997). The successful implementation of pharmaceutical practice guidelines: Analysis of associated outcomes and cost savings.
    • Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997). Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery.. JAMA, 277(8), 646 - 650.
    • BennettGuerrero E, Young LR, Wahl TA, Diers TL, Mythen MG (1997). Morbidity associated with prolonged hospital length of stay following moderate and high risk elective surgery. ANESTH ANALG, 84, S33 - S33.
    • BennettGuerrero E, Sorohan JG, Canada AT, Ayuso L, Newman MF, Reves JG, Mythen MG (1997). Epsilon-aminocaproic acid (amicar) plasma levels during cardiopulmonary bypass. ANESTH ANALG, 84, S62 - S62.
    • Welsby I, Mythen MG (1997). Gut perfusion during cardiac surgery. Current Opinion in Anaesthesiology, 10(1), 34 - 39. doi:10.1097/00001503-199702000-00010
    • Rombeau JL, Takala J, Carlet J, Carpentier , Evans TW, Fink MP, Furst P, Goris RJA, Groeneveld JAB, Haglund , Kubes P, Marshall JC, McVay L, Moore FA, Mythen M, Payen DM, Radermacher P, Redl H, Schumacker P, Singer M, Soeters P, Stoutenbeck C, Vallet N, Vincent JL, Wells CL, Zhang H, Ziegler TR (1997). Gut dysfunction in critical illness. Clinical Nutrition, 16(2), 57 - 60. doi:10.1016/S0261-5614(97)80023-4
    • Welsby I, Mythen M (1997). Plasma volume support in cardiac surgery. Bailliere's Clinical Anaesthesiology, 11(1), 105 - 125. doi:10.1016/S0950-3501(97)80007-4
    • Hamilton D, Mythen MG, Salmon JB, Jacobson D, Shukla A, Webb AR (1997). Comparison of commonly used clinical indicators of hypovolaemia with gastrointestinal tonometry. INTENSIVE CARE MED, 23(3), 276 - 281.
    • Welsby IJ, Gan TJ, Cooper A, Mythen M, Glass PSA (1997). Thromboelastographic changes following 6% hetastarch administration for the treatment of perioperative hypovolemia.. ANESTHESIOLOGY, 87(3), A136 - A136.
    • Gan TJ, Wakeling H, Hardman D, Booth JV, Chitester C, Ray J, Mythen M, Glass PSA (1997). Intraoperative volume expansion guided by esophageal Doppler reduces the incidence of gastric mucosal hypoperfusion and may be associated with improved outcome following major surgery. ANESTHESIOLOGY, 87(3), A391 - A391.
    • Bennett-Guerrero E, Sorohan JG, Canada AT, Ayuso L, Newman MF, Reves JG, Mythen MG (1997). epsilon-Aminocaproic acid plasma levels during cardiopulmonary bypass.. Anesth Analg, 85(2), 248 - 251.
    • Lubarsky DA, Glass PS, Ginsberg B, Dear GL, Dentz ME, Gan TJ, Sanderson IC, Mythen MG, Dufore S, Pressley CC, Gilbert WC, White WD, Alexander ML, Coleman RL, Rogers M, Reves JG (1997). The successful implementation of pharmaceutical practice guidelines. Analysis of associated outcomes and cost savings. SWiPE Group. Systematic Withdrawal of Perioperative Expenses.. Anesthesiology, 86(5), 1145 - 1160.
    • Layland M, Mythen MG, Wang KY, Albaladejo P, Leone BJ (1997). Measurement of gastrointestinal intramucosal pH is a poor guide to tolerable levels of anemia during isovolemic hemodilution in a canine model of coronary stenosis.. Arch Surg, 132(5), 547 - 552.
    • Haxby EJ, Gray MR, Rodriguez C, Nott D, Springall M, Mythen M (1997). Assessment of cardiovascular changes during laparoscopic hernia repair using oesophageal Doppler.. Br J Anaesth, 78(5), 515 - 519.
    • Gan TJ, Mythen MG, Glass PS (1997). Intraoperative gut hypoperfusion may be a risk factor for postoperative nausea and vomiting.. Br J Anaesth, 78(4), 476 - .
    • Segall PE, Sternberg H, Waitz HD, Letsou GV, Li Z, Mythen MG, Gan TJ (1997). Replacing blood volume in hypothermia and normothermia.. FASEB J, 11(3), 3037 - 3037.

    1996

    • Mythen MG, Croughwell ND, Lowry E, Kirchner JL, Newman MF (1996). Effect of warm cardiopulmonary bypass on splanchnic perfusion. ANESTHESIOLOGY, 85(3A), A81 - A81.
    • BennettGuerrero E, Ayuso L, HamiltonDavies C, White WD, Smith PK, Muhlbaier LH, Newman MF, Barclay GR, Mythen MG (1996). Preoperative anti-endotoxin-core antibody level and outcome following cardiac surgery. ANESTHESIOLOGY, 85(3A), A254 - A254.
    • Newman MF, Mythen M, Croughwell ND, Lowry E, Kirchner J, Smith PK, Jones RH, Reves JG (1996). The interaction of age, hemodilution and pressure flow autoregulation during cardiopulmonary bypass. ANESTH ANALG, 82(4), SCA36 - SCA36.
    • Layland M, Mythen MG, Wang KY, Albaladejo P, Leone BJ (1996). The effect of normovolemic hemodilution on gut mucosal perfusion in a model of coronary stenosis. ANESTH ANALG, 82(4), SC113 - SC113.
    • Mythen MG, Croughwell ND, Lowry E, Kirchner JL, Newman MF (1996). The relationship between gut mucosal perfusion and cerebral perfusion during cardiac surgery. ANESTH ANALG, 82(4), SC109 - SC109.
    • Croughwell ND, Lowry E, Mythen MG, White WD, Kirchner J, Clements F, Grichnik K, Newman MF (1996). Changes in serum biochemical markers of cerebral injury during cardiac surgery: S-100 levels and CABG. ANESTH ANALG, 82(4), SCA40 - SCA40.
    • BennettGuerrero E, Sorohan JG, Ayuso L, Cardigan RA, Newman MF, Mackie IJ, Mythen MG (1996). Effect of long-cardiopulmonary bypass duration on serum aprotinin pharmacokinetics using a high dose regimen. ANESTH ANALG, 82(4), SCA10 - SCA10.
    • Mythen MG, Purdy GC, Mackie IJ, Webb AR, Machin SJ (1996). There is significant neutrophil degranulation both before and during cardiopulmonary by-pass. ANESTH ANALG, 82(4), SCA26 - SCA26.
    • Bennett-Guerrero E, Sorohan JG, Howell ST, Ayuso L, Cardigan RA, Newman MF, Mackie IJ, Reves JG, Mythen MG (1996). Maintenance of therapeutic plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimen.. Anesth Analg, 83(6), 1189 - 1192.

    1995

    • Gan TJ, Mythen MG (1995). Does peroperative gut-mucosa hypoperfusion cause postoperative nausea and vomiting?. Lancet, 345(8957), 1123 - 1124.
    • Salmon JB, Mythen MG, Webb AR (1995). Tonometry to assess the adequacy of splanchnic oxygenation in the critically ill patient.. Intensive Care Med, 21(9), 777 - .
    • CORDINGLEY JJ, MYTHEN MG, PALAZZO M (1995). CHANGE IN GASTRIC INTRAMUCOSAL PH IS NOT ASSOCIATED WITH THE CHANGE IN TONOMETER PO-2 AFTER RESUSCITATION IN PATIENTS WITH SEPSIS. BRIT J ANAESTH, 74, 121 - 121.
    • DAVIES M, HAMILTONDAVIES C, MYTHEN M, REEVES P, BROMLEY L (1995). OUTCOME GOALS AND MINOR MORBIDITY FOLLOWING ELECTIVE CARDIAC-SURGERY. BRIT J ANAESTH, 74, 2 - 2.
    • HAXBY E, GRAY M, RODRIGUEZ C, NOTT D, SPRINGALL R, MYTHEN M (1995). ESOPHAGEAL DOPPLER ASSESSMENT OF HEMODYNAMIC-EFFECTS OF CO2 ABDOMINAL INSUFFLATION DURING LAPAROSCOPIC HERNIA REPAIR. BRIT J ANAESTH, 74, 10 - 10.
    • DAKIN M, FAWCETT A, SPRINGALL R, NOTT D, MYTHEN M (1995). DISCREPANCIES BETWEEN CHANGE IN MICROVASCULAR FLOW AT THE SITE OF LARGE-BOWEL ANASTAMOSES AND GASTRIC INTRAMUCOSAL PH DURING ELECTIVE COLORECTAL SURGERY. BRIT J ANAESTH, 74, 36 - 36.
    • Webb AR, Mythen MG, Jacobson D, Mackie IJ (1995). Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation.. Intensive Care Med, 21(1), 84 - 93.
    • Mythen MG, Webb AR (1995). Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery.. Arch Surg, 130(4), 423 - 429.

    1994

    • Mythen MG, Webb AR (1994). Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost.. Intensive Care Med, 20(2), 99 - 104.
    • Mythen MG, Salmon JB (1994). Gastric intramural PCO2 in peritonitis and shock.. Chest, 106(6), 1929 - 1930.
    • Mythen MG, Webb AR (1994). The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.. Intensive Care Med, 20(3), 203 - 209.
    • Higgins D, Mythen MG, Webb AR (1994). Low intramucosal pH is associated with failure to acidify the gastric lumen in response to pentagastrin.. Intensive Care Med, 20(2), 105 - 108.
    • Mythen MG (1994). Therapeutic interventions aimed at preventing organ failure. Anaesthetic Pharmacology Review, 2(2), 160 - 171.

    1993

    • Mythen MG, Barclay GR, Purdy G, Hamilton-Davies C, Mackie IJ, Webb AR, Machin SJ (1993). The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction.. Blood Coagul Fibrinolysis, 4(6), 999 - 1005.
    • MYTHEN MG, PURDY G, MACKIE IJ, MCNALLY T, WEBB AR, MACHIN SJ (1993). POSTOPERATIVE MULTIPLE ORGAN DYSFUNCTION SYNDROME-ASSOCIATED WITH GUT MUCOSAL HYPOPERFUSION, INCREASED NEUTROPHIL DEGRANULATION AND C1-ESTERASE INHIBITOR DEPLETION. BRIT J ANAESTH, 71(6), 858 - 863.
    • MYTHEN MG, PURDY G, BARCLAY GR, MACKIE IJ, WEBB AR, MACHIN SJ (1993). THE ROLE OF ENDOTOXIN IMMUNITY, NEUTROPHIL DEGRANULATION AND CONTACT ACTIVATION IN THE PATHOGENESIS OF POSTOPERATIVE ORGAN DYSFUNCTION. THROMB HAEMOSTASIS, 69(6), 726 - 726.
    • MYTHEN MG, PURDY GC, CARDIGAN RA, MACKIE IJ, WEBB AR, MACHIN SJ (1993). THERE IS SIGNIFICANT CONTACT ACTIVATION BEFORE RATHER THAN DURING CARDIOPULMONARY BYPASS. THROMB HAEMOSTASIS, 69(6), 870 - 870.
    • Salmon JB, Mythen MG (1993). Pharmacology and physiology of colloids.. Blood Rev, 7(2), 114 - 120.
    • MYTHEN M, BROWNE D, HAMILTONDAVIES C, WEBB A (1993). GASTRIC-MUCOSAL PERFUSION IS BETTER PRESERVED DURING CARDIAC-SURGERY WHEN ISOFLURANE RATHER THAN ENFLURANE OR PROPOFOL IS USED TO MAINTAIN ANESTHESIA. BRIT J ANAESTH, 70, 15 - 15.
    • Maynard ND, Atkinson S, Pierre DR, Schlichting E, Lyberg T, Mythen MG, Salmon JB, Webb AR (1993). Routine blood-gas analysis and gastric tonometry for intramural pH [8]. Lancet, 341(8846), 691 - 693.
    • Mythen MG, Salmon JB, Webb AR (1993). Routine blood-gas analysis and gastric tonometry for intramural pH.. Lancet, 341(8846), 692 - 693.
    • HIGGINS D, MYTHEN MG, STURGESS RP, WEBB AR (1993). LOW INTRAMUCOSAL PH AND FAILURE TO ACIDIFY THE GASTRIC LUMEN IN RESPONSE TO PENTAGASTRIN. GASTROENTEROLOGY, 104(4), A252 - A252.
    • MYTHEN MG, PURDY G, MACKIE IJ, WEBB AR, MACHIN SJ (1993). INCREASED NEUTROPHIL DEGRANULATION ASSOCIATED WITH GASTRIC-MUCOSAL HYPOPERFUSION. GASTROENTEROLOGY, 104(4), A267 - A267.
    • Mythen MG, Salmon JB, Webb AR (1993). The rational administration of colloids.. Blood Rev, 7(4), 223 - 228.

    1992

    • Webb AR, Moss RF, Tighe D, Mythen MG, al-Saady N, Joseph AE, Bennett ED (1992). A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis.. Intensive Care Med, 18(6), 348 - 355.

    1987

    • Payne RA, Joynson DH, Balfour AH, Harford JP, Fleck DG, Mythen M, Saunders RJ (1987). Public Health Laboratory Service enzyme linked immunosorbent assay for detecting Toxoplasma specific IgM antibody.. J Clin Pathol, 40(3), 276 - 281.